With the Pharma & Medical division, which was founded in 2023, we offer innovative, highly efficient process and production systems specially developed for the complex needs of the pharmaceutical and medical industry.
First of all, our novel method for inactivating RNases. This patent-pending approach provides an outstanding solution for the inhibition of RNases in single-use bioprocess containers, single-use assemblies and laboratory equipment by non-thermal plasma.
In addition, we supply the industry with highly efficient semi- and fully automated
production systems for 2D and 3D single-use bioprocess containers.
Discover the 3CON Pharma | Medical solutions:
Nuestros expertos le asesorarán con mucho gusto.